Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Macy's Inc (M) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Macy's Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.96 (market cap $8.48B), while Macy's Inc trades at $22.62 (market cap $5.94B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Macy's Inc pays a 3.37% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Macy's Inc for 58 Days on average.
| HNGE | M | |
|---|---|---|
Market Cap | $8.48B | $5.94B |
Volume | 879,799 | 4,634,768 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $26.21 |
52-Week Low | $31.17 | $16.92 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $8.10B | $9.73B |
Dividend Yield | — | 3.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Macy's (M) trades at $22.74, down 1.09% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation with a P/E of 8.33 and P/S of 0.27. Recent earnings have consistently beaten estimates, and the company's 'A Bold New Chapter' strategy is driving digital and omnichannel growth, supporting a raised 2026 outlook despite near-term investment pressures.
The outlook is cautiously optimistic, with upside to the $24.25 consensus price target. Investment opportunities include a sustainable dividend yield and undervaluation relative to peers. Key risks are soft second-half comps, margin pressure from tariffs, and intense retail competition. Execution of the turnaround strategy remains critical for sustained shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →
